Last reviewed · How we verify
Perforation of cornea
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Lotemax · Bausch Health
- Tobi · Novartis
- Lotemax · Tufts Medical Center
- Decadron · Generic (originally Merck)
- Vantobra · Pfizer
- Nebcin · University Hospital, Lille
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Perforation of cornea patent landscape — cliff calendar, originator estates, attackable patents
- Perforation of cornea treatment landscape brief
- Perforation of cornea treatment updates RSS
Frequently asked questions about Perforation of cornea
What drugs treat Perforation of cornea?
Tracked treatments include Ramycin, Lotemax, Tobi, Decadron, Vantobra, Nebcin.
What is the treatment for Perforation of cornea?
Standard treatment for Perforation of cornea includes Ramycin, Lotemax, Tobi, Decadron, Vantobra. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Perforation of cornea patent cliff · Perforation of cornea CI report
- Treatment: Ramycin
- Treatment: Lotemax · Bausch Health
- Treatment: Tobi · Novartis
- Treatment: Lotemax · Tufts Medical Center
- Treatment: Decadron · Generic (originally Merck)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing